Efficacy and safety of platinum-based, anthracycline-free neoadjuvant chemotherapy for triple-negative breast cancer: a systematic review and meta-analysis
Abstract Objective This study examines the effectiveness of platinum-based anthracycline-free neoadjuvant chemotherapy (NAC) combined with taxanes in treating triple-negative breast cancer (TNBC). Methods Studies published up to January 2025 were systematically retrieved from PubMed, Web of Science,...
Saved in:
| Main Authors: | Yichao Du, Lu Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-08-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-03435-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of platinum-based antineoplastic drugs and their impact on complete pathological response and prognosis in patients with BRCA-associated triple-negative breast cancer after neoadjuvant treatment: a single institution experience
by: D. A. Enaldieva, et al.
Published: (2023-06-01) -
Oral microbiome components predict response to neoadjuvant chemotherapy in triple-negative breast cancer patients
by: Xiaoyan Fu, et al.
Published: (2025-07-01) -
The effect of neoadjuvant chemotherapy on ductal carcinoma in situ in triple-negative breast cancer patients: A nationwide analysis
by: Eva L. Claassens, et al.
Published: (2025-04-01) -
The role of epidermal growth factor receptor (EGFR) in the efficacy of neoadjuvant chemotherapy in triple-negative breast cancer patients
by: N. N. Babyshkina, et al.
Published: (2020-04-01) -
The utility of immunohistochemistry-based biomarkers in predicting the pathological complete response in early-stage triple-negative breast cancer
by: Chikako Funasaka, et al.
Published: (2025-01-01)